Insider Buy/Sell Ratio - USA Drug Manufacturers, CEO : 4.67 (As of 2024-05-01)
Historical Data
Total 166
Basic Info
Insider Buy/Sell Ratio - USA Drug Manufacturers, CEO was 4.67 as of 2024-05-01, according to GuruFocus. Historically, Insider Buy/Sell Ratio - USA Drug Manufacturers, CEO reached a record high of 11 and a record low of 0.04, the median value is 0.5. Typical value range is from 0.04 to 1.83. The Year-Over-Year growth is 422.35%. GuruFocus provides the current actual value, an historical data chart and related indicators for Insider Buy/Sell Ratio - USA Drug Manufacturers, CEO - last updated on 2024-05-01.
Monthly data, but the recent month data is updated daily. Note that the monthly insider buy/sell ratio for the current month is calculated based on insider buy/sell transactions within 30 days.
Category | Market Trend |
Region | USA |
Source | GuruFocus |
Stats
Name | Value | ||
---|---|---|---|
Last Value | 4.67 | ||
Latest Period | 2024-05-01 | ||
Long Term Average | 0.80 | ||
Average Annualized Growth Rate | +15.75% | ||
Value from 1 year ago | 0.89 | ||
Change from 1 year ago | +424.72% | ||
Frequency | Daily | ||
Unit |
Related Indicators
Discussions on Insider Buy/Sell Ratio - USA Drug Manufacturers, CEO
No discussions yet.